• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于糖蛋白H缺失的单纯疱疹病毒载体的体内互补研究。

In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector.

作者信息

Speck P G, Efstathiou S, Minson A C

机构信息

Department of Pathology, University of Cambridge, UK.

出版信息

J Gen Virol. 1996 Oct;77 ( Pt 10):2563-8. doi: 10.1099/0022-1317-77-10-2563.

DOI:10.1099/0022-1317-77-10-2563
PMID:8887491
Abstract

The utilization of herpes simplex virus (HSV) as a vector for gene delivery to the nervous system or as a live vaccine delivery system is dependent on the construction and characterization of disabled virus mutants which are unable to cause disease. Under certain circumstances, however, replication-defective vectors may carry a potential risk if they can be efficiently complemented by a co-infecting wild-type virus. Stocks of defective vectors should, therefore, be free from replication-competent virus, and helper cell lines should be incapable of generating replication-competent virus by recombination between the vector and the complementary gene. We describe a glycoprotein H-negative (gH-) virus/helper cell line combination which generates helper-free defective virus stocks containing replication-competent virus at a frequency no higher than 1 in 10(9) p.f.u. This virus/helper cell system provides a suitable background for the construction of safe replication-defective gene delivery vectors. In vivo studies demonstrate that gH- virus is unable to initiate disease in mice and establishes latency at low efficiency compared to wild-type HSV. To determine whether gH- virus can be complemented by wild-type virus in vivo, mice were infected with a variety of mixtures of these viruses. Complementation was observed in a minority of animals infected with more than 10(6) p.f.u. of both wild-type and defective virus but the most common observation was that the presence of defective virus suppressed entry of wild-type virus into the nervous system.

摘要

单纯疱疹病毒(HSV)作为一种将基因传递至神经系统的载体或作为一种活疫苗递送系统,其应用依赖于构建和鉴定无致病能力的缺陷病毒突变体。然而,在某些情况下,如果复制缺陷型载体能够被共感染的野生型病毒有效互补,那么它们可能存在潜在风险。因此,缺陷型载体的毒株应不含具有复制能力的病毒,并且辅助细胞系应无法通过载体与互补基因之间的重组产生具有复制能力的病毒。我们描述了一种糖蛋白H阴性(gH-)病毒/辅助细胞系组合,该组合产生的无辅助缺陷型病毒毒株中,含有复制能力病毒的频率不高于10^9个噬斑形成单位(p.f.u.)中的1个。这种病毒/辅助细胞系统为构建安全的复制缺陷型基因传递载体提供了合适的背景。体内研究表明,与野生型HSV相比,gH-病毒无法在小鼠体内引发疾病,且以低效率建立潜伏感染。为了确定gH-病毒在体内是否能被野生型病毒互补,用这些病毒的多种混合物感染小鼠。在少数感染了超过10^6个p.f.u.野生型和缺陷型病毒的动物中观察到了互补现象,但最常见的情况是缺陷型病毒的存在抑制了野生型病毒进入神经系统。

相似文献

1
In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector.基于糖蛋白H缺失的单纯疱疹病毒载体的体内互补研究。
J Gen Virol. 1996 Oct;77 ( Pt 10):2563-8. doi: 10.1099/0022-1317-77-10-2563.
2
Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.单纯疱疹病毒1型重组载体与扩增子载体联用:复制能力完整型与缺陷型及其对实验性胶质瘤的治疗效果
J Gene Med. 1999 May-Jun;1(3):176-85. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<176::AID-JGM35>3.0.CO;2-T.
3
Construction of replication-defective herpes simplex virus vectors.
Curr Protoc Hum Genet. 2002 Aug;Chapter 12:Unit 12.11. doi: 10.1002/0471142905.hg1211s33.
4
Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.多种立即早期基因缺陷型单纯疱疹病毒载体可实现高效的基因传递至培养中的神经元,并在体内广泛地将基因传递至中枢神经系统。
J Virol. 2001 May;75(9):4343-56. doi: 10.1128/JVI.75.9.4343-4356.2001.
5
Replication-Competent Controlled Herpes Simplex Virus.具有复制能力的可控单纯疱疹病毒
J Virol. 2015 Oct;89(20):10668-79. doi: 10.1128/JVI.01667-15. Epub 2015 Aug 12.
6
Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.利用IE 2缺失突变体产生高滴度缺陷型单纯疱疹病毒1型载体并对培养的皮质细胞中的表达进行定量研究。
Biotechniques. 1996 Mar;20(3):460-9. doi: 10.2144/19962003460.
7
Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.人免疫缺陷病毒长末端重复序列在无复制能力的单纯疱疹病毒载体中的可诱导基因表达。
Virology. 1996 Dec 1;226(1):127-31. doi: 10.1006/viro.1996.0635.
8
Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.用于生产复制缺陷型单纯疱疹病毒1型(HSV-1)基因治疗载体的工程细胞系。
Biotechnol Bioeng. 2009 Mar 1;102(4):1087-97. doi: 10.1002/bit.22123.
9
Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.1型单纯疱疹病毒DNA在大肠杆菌中作为细菌人工染色体进行扩增:拯救具有复制能力的病毒后代及扩增子载体的包装
Hum Gene Ther. 1998 Dec 10;9(18):2787-94. doi: 10.1089/hum.1998.9.18-2787.
10
An efficient selection system for packaging herpes simplex virus amplicons.一种用于包装单纯疱疹病毒扩增子的高效筛选系统。
J Gen Virol. 1998 Jan;79 ( Pt 1):125-31. doi: 10.1099/0022-1317-79-1-125.

引用本文的文献

1
Coinfection in the host can result in functional complementation between live vaccines and virulent virus.宿主中的共感染会导致活疫苗和强毒病毒之间的功能互补。
Virulence. 2022 Dec;13(1):980-989. doi: 10.1080/21505594.2022.2082645.
2
Herpes simplex virus interference with immunity: Focus on dendritic cells.单纯疱疹病毒对免疫的干扰:以树突状细胞为焦点。
Virulence. 2021 Dec;12(1):2583-2607. doi: 10.1080/21505594.2021.1980990.
3
A codon-shuffling method to prevent reversion during production of replication-defective herpesvirus stocks: Implications for herpesvirus vaccines.
一种在生产复制缺陷型疱疹病毒时防止回复的密码子改组方法:对疱疹病毒疫苗的影响。
Sci Rep. 2017 Mar 13;7:44404. doi: 10.1038/srep44404.
4
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.糖蛋白D缺失的2型单纯疱疹病毒可预防阴道、皮肤和神经疾病。
Elife. 2015 Mar 10;4:e06054. doi: 10.7554/eLife.06054.
5
Herpes simplex virus-based vectors.基于单纯疱疹病毒的载体。
Int J Exp Pathol. 2004 Oct;85(4):177-90. doi: 10.1111/j.0959-9673.2004.00383.x.
6
Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.单纯疱疹病毒载体在宿主已有免疫力的情况下能引发持久的免疫反应。
J Virol. 2002 Apr;76(8):3678-87. doi: 10.1128/jvi.76.8.3678-3687.2002.
7
Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.在存在免疫T细胞的情况下,疫苗诱导产生的血清免疫球蛋白有助于预防2型单纯疱疹病毒引起的生殖器感染。
J Virol. 2001 Feb;75(3):1195-204. doi: 10.1128/JVI.75.3.1195-1204.2001.
8
Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.单纯疱疹病毒2型UL5/UL29双缺失突变体的构建、表型分析及免疫原性
J Virol. 2000 Sep;74(17):7963-71. doi: 10.1128/jvi.74.17.7963-7971.2000.
9
Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.使用在增殖性感染和潜伏性感染方面存在缺陷的疫苗病毒对生殖器疱疹进行免疫接种。
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6994-8. doi: 10.1073/pnas.96.12.6994.